Bayesian randomized clinical trials: A decision-theoretic sequential design (Q4673116): Difference between revisions
From MaRDI portal
Set profile property. |
ReferenceBot (talk | contribs) Changed an Item |
||
| (One intermediate revision by one other user not shown) | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2119290807 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Q4363933 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Approaches for Optimal Sequential Decision Analysis in Clinical Trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes / rank | |||
Normal rank | |||
Latest revision as of 10:42, 10 June 2024
scientific article; zbMATH DE number 2162641
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian randomized clinical trials: A decision-theoretic sequential design |
scientific article; zbMATH DE number 2162641 |
Statements
Bayesian randomized clinical trials: A decision-theoretic sequential design (English)
0 references
29 April 2005
0 references
backward induction
0 references
robustness
0 references
utility functions
0 references
0 references
